Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00233103 · ClinicalTrials.gov registry record · Phase 2
Treatment of Post-Traumatic Brain Injury (TBI) Depression
A Phase 2 study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 2
- Development phase
- 52
- Enrollment target
NCT00233103 is a Phase 2 study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 52 participants.
The verdict
NCT00233103, a Phase 2 study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 52 participants
- Enrollment target
Study Summary
Randomized clinical trial of sertraline vs. placebo for post-TBI depression
Interventions
- DRUG Placebo
- DRUG Sertraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2003-06 |
| Est. Completion | 2008-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00233103
The ClinicalTrials.gov registry entry for NCT00233103 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00233103 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00233103 about?
NCT00233103 is a clinical study titled "Treatment of Post-Traumatic Brain Injury (TBI) Depression". Randomized clinical trial of sertraline vs. placebo for post-TBI depression
What is the current status of trial NCT00233103?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 52 participants. The study started on 2003-06. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00233103?
The interventions under investigation include: Placebo (DRUG), Sertraline (DRUG).
Who is sponsoring clinical trial NCT00233103?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.